Big Pharma Says Drug Prices Reflect R&D Cost. Researchers Call BS (Wired)
United States. The ALS community rejoiced; the drug’s authorization was described as a “long-sought victory for patients.” But the next day, the price of the medicine was revealed: $158,000 a year. This was far higher than what the Institute for Clinical and Economic Review, an independent nonprofit that analyzes health care costs, had estimated would be a reasonable price, which […]
Big Pharma Says Drug Prices Reflect R&D Cost. Researchers Call BS (Wired) Read More »